In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).
Contains 12 practice-oriented topics including CAR T-cells in aggressive B-cell lymphomas; CAR T-cells in multiple myeloma; CAR T-cells in AML; mechanisms of resistance of CAR T-cell therapy; the role of CAR T-cell therapy in the era of bispecific antibodies; and more.
Provides in-depth clinical reviews on CAR T-cell therapy, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia - p. 1041 9. Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma - p. 1053 10. Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia - p. 1077 11. Chimeric Antigen Receptor T Cells in Multiple Myeloma - p. 1089 12. Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas - p. 1107 13. Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia - p. 1125 14. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors - p. 1149 15. Early and Late Toxicities of Chimeric Antigen Receptor T-Cells - p. 1169 16. Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy - p. 1189 17. The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies - p. 1201 18. The Future of Chimeric Antigen Receptor T Cell Therapy - p. 1215
In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).
Contains 12 practice-oriented topics including CAR T-cells in aggressive B-cell lymphomas; CAR T-cells in multiple myeloma; CAR T-cells in AML; mechanisms of resistance of CAR T-cell therapy; the role of CAR T-cell therapy in the era of bispecific antibodies; and more.
Provides in-depth clinical reviews on CAR T-cell therapy, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia - p. 1041 9. Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma - p. 1053 10. Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia - p. 1077 11. Chimeric Antigen Receptor T Cells in Multiple Myeloma - p. 1089 12. Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas - p. 1107 13. Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia - p. 1125 14. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors - p. 1149 15. Early and Late Toxicities of Chimeric Antigen Receptor T-Cells - p. 1169 16. Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy - p. 1189 17. The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies - p. 1201 18. The Future of Chimeric Antigen Receptor T Cell Therapy - p. 1215
